Financials
- Market Capitalization 583.83 M
- Employee 21
- Founded 2012
- CEO N/A
- Website www.immixbio.com
- Headquarter Delaware, United States
- FIGI BBG00HLCWH09
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 2800 | FBRX Forte Biosciences, Inc. - Common Stock | 43.58 USD | -1.22% | +92.07% | +145.66% | +48.48% | 605.14 M USD | ||
| 2804 | FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 11.82 USD | +4.60% | -7.94% | +30.75% | +4.60% | 617.91 M USD | ||
| 2821 | NGNE Neurogene Inc. - Common Stock | 39.19 USD | +2.27% | +8.02% | +33.57% | +33.21% | 619.28 M USD | ||
| 2833 | DRUG Bright Minds Biosciences Inc. - common stock | 76.26 USD | +0.43% | +18.97% | +23.30% | +193.76% | 582.31 M USD |